Acta Neuropathol

1. NASSIRI F, Ajisebutu A, Patil V, Mamatjan Y, et al
   Metabologenomic characterization uncovers a clinically aggressive IDH mutant glioma subtype.
   Acta Neuropathol. 2024;147:68.
   

   >> Share

   
   

   
   AJNR Am J Neuroradiol

2. KIM JT, Chang SJC, Haghdel A, Ramakrishna RR, et al
   DOTATATE PET/MR Imaging Differentiates Secondary-Progressive from de Novo World Health Organization Grade 3 Meningiomas.
   AJNR Am J Neuroradiol. 2024 Apr 11. doi: 10.3174/ajnr.A8219.
   

   >> Share

   
   
3. SONI N, Agarwal A, Ajmera P, Mehta P, et al
   High-Grade Astrocytoma with Piloid Features: A Dual Institutional Review of Imaging Findings of a Novel Entity.
   AJNR Am J Neuroradiol. 2024;45:468-474.
   

   >> Share

   
   
4. KOBAYASHI M, Kato S, Demura S, Yokogawa N, et al
   Evaluation of Conditions for the Development of Cryogenic Spinal Cord Injury Using a Canine Model: An Experimental Study on the Safety of Cryoablation for Metastatic Spinal Tumors.
   AJNR Am J Neuroradiol. 2024;45:424-431.
   

   >> Share

   
   
5. CERRON-VELA C, Goncalves FG, Viaene AN, Tierradentro-Garcia LO, et al
   Expanding the Imaging Spectrum of Polymorphous Low-Grade Neuroepithelial Tumor of the Young in Children.
   AJNR Am J Neuroradiol. 2024;45:483-487.
   

   >> Share

   
   

   
   BMC Cancer

6. CHEN M, Li R, Kong Y, Shi L, et al
   Rational and design of prophylactic cranial irradiation (PCI) and brain MRI surveillance versus brain MRI surveillance alone in patients with limited-stage small cell lung cancer achieving complete remission (CR) of tumor after chemoradiotherapy: a mu
   BMC Cancer. 2024;24:429.
   

   >> Share

   
   
7. KONG C, Yin X, Zou J, Ma C, et al
   The application of different machine learning models based on PET/CT images and EGFR in predicting brain metastasis of adenocarcinoma of the lung.
   BMC Cancer. 2024;24:454.
   

   >> Share

   
   
8. DENG MY, da Silva AS, Goller PC, Konig L, et al
   Plasma extracellular vesicles in meningioma patients following radiotherapy as liquid biopsy- a prospective explorative biomarker study (ARO 2023-05/AG-NRO-07).
   BMC Cancer. 2024;24:449.
   

   >> Share

   
   

   
   Childs Nerv Syst

9. CICUTTI SE, Del Rio RJ, Caceres A, Gonzalez Ramos JD, et al
   Pediatric hemispheric cerebellar low-grade gliomas: clinical approach, diagnosis, and management challenges-experience at a tertiary care children's hospital.
   Childs Nerv Syst. 2024 Apr 12. doi: 10.1007/s00381-024-06394.
   

   >> Share

   
   

   
   Clin Neuropathol

10. SUNIL A, Thakar S, Murali SH, Sriramanakoppa NN, et al
    Olfactory groove schwannoma: Common pathology in an uncommon location.
    Clin Neuropathol. 2024;43:65-68.
    

    >> Share

    
    

    
    J Neurooncol

11. KONDO N, Kinouchi T, Natsumeda M, Matsuzaki J, et al
    Profile of miRNAs in small extracellular vesicles released from glioblastoma cells treated by boron neutron capture therapy.
    J Neurooncol. 2024 Apr 10. doi: 10.1007/s11060-024-04649.
    

    >> Share

    
    
12. CHEN KT, Huang CY, Pai PC, Yang WC, et al
    Correction to: Focused ultrasound combined with radiotherapy for malignant brain tumor: a preclinical and clinical study.
    J Neurooncol. 2024 Apr 10. doi: 10.1007/s11060-024-04671.
    

    >> Share

    
    
13. SHEEHAN JP, Trifiletti DM, Lehrer EJ
    Tissue biopsy before resection in glioblastoma: is there an opportunity to improve outcomes with liquid biopsies and pre-operative stereotactic radiosurgery?
    J Neurooncol. 2024 Apr 11. doi: 10.1007/s11060-024-04678.
    

    >> Share

    
    

    
    J Neuropathol Exp Neurol

14. WILCOCK DM, Goold E, Zuromski LM, Davidson C, et al
    EGFR/CEP7 high polysomy is separate and distinct from EGFR amplification in glioblastoma as determined by fluorescence in situ hybridization.
    J Neuropathol Exp Neurol. 2024 Apr 11:nlae028. doi: 10.1093.
    

    >> Share

    
    

    
    J Neurosurg

15. QI Y, Xu Y, Yan T, Xiong W, et al
    Use of circulating tumor cells and microemboli to predict diagnosis and prognosis in diffuse glioma.
    J Neurosurg. 2024 Apr 12:1-11. doi: 10.3171/2024.1.JNS232020.
    

    >> Share

    
    

    
    Neuro Oncol

16. ANASTASAKI C, Chatterjee J, Koleske JP, Gao Y, et al
    NF1 mutation-driven neuronal hyperexcitability sets a threshold for tumorigenesis and therapeutic targeting of murine optic glioma.
    Neuro Oncol. 2024 Apr 12:noae054. doi: 10.1093.
    

    >> Share

    
    
17. TOHIDINEZHAD F, Zegers CML, Vaassen F, Dijkstra J, et al
    Predicting the risk of neurocognitive decline after brain irradiation in adult patients with a primary brain tumor.
    Neuro Oncol. 2024 Apr 10:noae035. doi: 10.1093.
    

    >> Share

    
    
18. GEURTS M, Preusser M
    Locoregional delivery of CAR-T cells - breaking the spell in glioblastoma?
    Neuro Oncol. 2024 Apr 9:noae063. doi: 10.1093.
    

    >> Share

    
    
19. ARRILLAGA-ROMANY I, Miller JJ
    Demonstrated efficacy and mechanisms of sensitivity of ONC201: H3K27M-mutant diffuse midline glioma in the spotlight.
    Neuro Oncol. 2024 Apr 8:noae051. doi: 10.1093.
    

    >> Share

    
    
20. CIOFFI G, Waite KA, Price M, Neff C, et al
    The impact of COVID-19 on 2020 monthly incidence trends of primary brain and other CNS tumors.
    Neuro Oncol. 2024;26:764-774.
    

    >> Share

    
    
21. APPIN CL, Hong C, Suwala AK, Hilz S, et al
    Whole tumor analysis reveals early origin of the TERT promoter mutation and intercellular heterogeneity in TERT expression.
    Neuro Oncol. 2024;26:640-652.
    

    >> Share

    
    
22. DUMOT C, Mantziaris G, Dayawansa S, Peker S, et al
    Stereotactic radiosurgery for nonfunctioning pituitary tumor: A multicenter study of new pituitary hormone deficiency.
    Neuro Oncol. 2024;26:715-723.
    

    >> Share

    
    
23. BUDHU JA, Chukwueke UN, Jackson S, Lee EQ, et al
    Defining interventions and metrics to improve diversity in CNS clinical trial participation: A SNO and RANO effort.
    Neuro Oncol. 2024;26:596-608.
    

    >> Share

    
    
24. BROMBERG JEC, Issa S, van der Holt B, van der Meulen M, et al
    Survival, neurocognitive function, and health-related quality of life outcomes after rituximab-methotrexate, BCNU, teniposide, and prednisolone for primary CNS lymphoma: Final results of the HOVON 105/ALLG NHL 24 study.
    Neuro Oncol. 2024;26:724-734.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share